Recombinant Bacillus subtilis spores expressing cholera toxin B subunit and Helicobacter pylori urease B confer protection against H. pylori in mice
Authors:
- 1 January 2017
- journal article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 66 (1) , 83-89
Abstract
Helicobacter pylori infection is associated with chronic gastritis, peptic ulcers, gastric cancer and mucosa-associated lymphoid tissue lymphoma. The limitations of current therapies for H. pylori infection include poor compliance and antibiotic resistance. Therefore, an effective anti-H. pylori vaccine would be an alternative or complement to antibiotic treatment. Urease B (UreB) is considered an ideal vaccine antigen against H. pylori infection. In this study, cholera toxin B subunit (CTB), a mucosal adjuvant, was used to enhance the immunogenicity of a novel Bacillus subtilis spore vaccine expressing CTB-UreB, along with the B. subtilis spore coat protein CotC as a fusion protein. Oral administration of B. subtilis spores expressing CotC-UreB or CotC-CTB-UreB led to increased levels of UreB-specific IgG in serum and UreB-specific IgA in faeces, as well as elevated levels of IL-10 and IFN-γ in splenocytes. In addition, oral administration of CotC-UreB or CotC-CTB-UreB spores induced significant reductions (80.0 and 90.5 %, respectively) in gastric H. pylori bacterial load (1.11±0.36×105 and 0.53±0.21×105 c.f.u., respectively) compared to that of the CotC control group (5.56±1.64×105 c.f.u., P<0.01). Moreover, CotC-CTB-UreB spores were significantly more effective at reducing the bacterial load than CotC-UreB spores (P<0.05). These results indicate that CotC-CTB-UreB-expressing B. subtilis spores are a potential vaccine candidate for the control of H. pylori infection.Keywords
This publication has 39 references indexed in Scilit:
- Immunization with Heat Shock Protein A and γ-Glutamyl Transpeptidase Induces Reduction on the Helicobacter pylori Colonization in MicePLOS ONE, 2015
- Challenges to the Treatment and New Perspectives for the Eradication of Helicobacter pyloriDigestive Diseases and Sciences, 2015
- High yield purification of Helicobacter pylori neutrophil-activating protein overexpressed in Escherichia coliBMC Biotechnology, 2015
- Effect of posture on13C-urea breath test in partial gastrectomy patientsWorld Journal of Gastroenterology, 2015
- A multi-epitope vaccine CTB-UE relievesHelicobacter pylori-induced gastric inflammatory reaction via up-regulating microRNA-155 to inhibit Th17 response in C57/BL6 mice modelHuman Vaccines & Immunotherapeutics, 2014
- Helicobacter pylorivaccination: Is there a path to protection?World Journal of Gastroenterology, 2014
- Prevalence of Primary and Secondary Antimicrobial Resistance of Helicobacter pylori in Korea from 2003 through 2012Helicobacter, 2012
- Global burden of cancers attributable to infections in 2008: a review and synthetic analysisThe Lancet Oncology, 2012
- Vaccinating against Helicobacter pylori infectionNature Reviews Gastroenterology & Hepatology, 2011
- Protective efficacy of recombinant urease B and aluminum hydroxide against Helicobacter pylori infection in a mouse modelFEMS Immunology & Medical Microbiology, 2010